YOLFTbeta
00

Luoxin Pharmaceuticals Group Stock Co Ltd

002793 · SHE · Healthcare / Drug Manufacturers - Specialty & Generic

3.93CNY-0.08 (-2.00%)

Price History

Full chart

Market Stats

Previous Close4.01
Open4.00
Day Range3.91 – 4.01
52-Week Range3.70 – 5.84
Volume12.64M
Market Cap5.24B
P/E (TTM)0.00
Forward P/E0.00
EPS-0.24
Dividend Yield0.00%
Beta0.26
50-Day Avg4.89
200-Day Avg4.81

About

Luoxin Pharmaceuticals Group Stock Co., Ltd. engages in the research and development, production, and sales of pharmaceutical products in China. The company provides anti-infective active pharmaceutical ingredients(APIs), antiviral APIs, respiratory and digestive system, nervous and endocrine system, cardiovascular system, oncology, and anti-allergic APIs and intermediates, as well as antipyretic, analgesics, and anti-inflammatory APIs and intermediates. It also offers health care services. Luoxin Pharmaceuticals Group Stock Co., Ltd. was formerly known as Zhejiang Doyin Pump Industry Co., Ltd. and changed its name to Luoxin Pharmaceuticals Group Stock Co., Ltd. in April 2020. The company was founded in 1998 and is based in Linyi, China.

Company Details

  • SectorHealthcare
  • IndustryDrug Manufacturers - Specialty & Generic
  • CEOMr. Zhenteng Liu
  • Employees2.96K
  • HeadquartersNo. 18, Luoqi Road, Linyi, China, 276017, China
  • Websitehttps://www.luoxin.cn

Leadership

  • Mr. Zhenteng LiuGM & Chairman · b. 1986
  • Mr. Yung-Sheng WuFinance Officer · b. 1983
  • Hongxing ZhangAccounting Supervisor

Financials

Income Statement

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue423.43M2.23B2.53B2.77B3.61B4.12B828.04M6.21B7.59B6.10B6.48B3.59B2.36B2.65B2.27B
Growth (%)-+426.24%+13.52%+9.38%+30.53%+14.02%-79.89%+650.12%+22.18%-19.67%+6.26%-44.62%-34.11%+11.99%-14.12%
Cost of Revenue336.47M722.02M884.39M874.02M1.13B998.00M575.82M1.93B2.80B2.85B3.23B2.69B1.34B1.61B1.14B
Gross Profit86.96M1.51B1.65B1.89B2.48B3.12B252.22M4.28B4.79B3.25B3.25B893.98M1.02B1.04B1.13B
Gross Margin20.54%67.60%65.04%68.41%68.61%75.76%30.46%68.86%63.07%53.28%50.10%24.92%43.33%39.30%49.65%
Operating Expense45.30M1.01B1.27B1.59B2.27B3.09B118.56M3.71B4.06B2.82B2.77B2.35B1.61B2.00B1.27B
Operating Income41.66M493.19M371.00M300.66M211.35M31.55M133.66M566.14M725.06M424.10M476.76M-1.46B-586.48M-958.50M-141.55M
Operating Margin9.84%22.13%14.67%10.87%5.85%0.77%16.14%9.11%9.55%6.96%7.36%-40.67%-24.81%-36.21%-6.23%
EBITDA49.12M542.95M534.51M587.76M635.94M541.73M157.12M698.39M927.06M629.20M777.93M-1.13B-336.96M-695.88M-29.17M
EBITDA Margin11.60%24.37%21.13%21.24%17.61%13.16%18.97%11.24%12.22%10.32%12.01%-31.45%-14.25%-26.29%-1.28%
Net Income32.52M439.87M428.58M443.55M492.93M379.20M115.85M512.32M633.95M320.70M406.10M-1.22B-661.14M-965.50M-288.58M
Net Income Margin7.68%19.74%16.94%16.03%13.65%9.21%13.99%8.25%8.35%5.26%6.27%-34.14%-27.97%-36.47%-12.69%
R&D13.64M78.06M70.62M122.00M253.61M314.31M30.95M419.88M419.99M361.27M320.95M204.73M112.27M87.41M91.60M
R&D as % of Total Revenue3.22%3.50%2.79%4.41%7.02%7.63%3.74%6.76%5.53%5.93%4.95%5.71%4.75%3.30%4.03%
Interest Expense5.25M03.35M2.64M3.81M2.92M716.60K4.14M48.09M51.21M106.49M129.45M75.97M65.69M55.59M
Interest Expense % of Total Revenue1.24%0.00%0.13%0.10%0.11%0.07%0.09%0.07%0.63%0.84%1.64%3.61%3.21%2.48%2.45%

Balance Sheet

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets271.94M372.31M363.30M447.86M549.60M812.89M898.93M1.40B7.46B7.72B9.50B8.11B5.12B4.34B3.73B
Total Liabilities120.07M166.77M111.80M132.40M210.10M114.56M144.74M491.85M3.50B3.37B4.76B4.80B2.54B2.88B2.49B
Total Equity151.87M205.54M251.50M315.46M339.50M698.33M754.19M909.89M3.68B4.04B4.38B3.17B2.47B1.38B1.16B
Cash65.30M64.18M52.64M48.88M79.97M140.13M125.76M323.35M1.11B1.29B2.00B1.43B692.90M456.68M550.11M
Total Debt21.47M74.71M22.19M31.14M100.42M--328.45M1.24B1.43B2.85B3.52B1.02B909.15M-
Net Debt-43.83M10.54M-30.45M-17.74M20.45M-140.13M-125.76M5.10M136.34M138.70M844.98M2.08B331.01M452.47M418.81M

Cash Flow

Currency: CNY2011-12-312012-12-312013-12-312014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow46.53M33.31M64.75M41.83M58.12M72.74M102.27M114.12M116.33M-32.40M120.63M-939.13M552.79M-157.85M253.07M
Investing Cash Flow-22.96M-79.47M-16.32M-51.90M-41.70M-157.38M-54.83M-284.74M-747.75M107.94M-428.42M-119.18M906.96M-1.34M-
Financing Cash Flow21.19M46.32M-55.50M6.96M6.48M155.46M-60.66M365.09M615.61M130.71M789.53M384.98M-1.72B-134.13M-
Capital Expenditure23.31M80.96M19.48M55.58M41.73M71.01M161.07M187.87M580.58M360.76M309.03M194.82M242.39M115.35M32.18M
Free Cash Flow23.22M-47.65M45.27M-13.75M16.39M1.74M-58.79M-73.76M-464.25M-393.16M-188.40M-1.13B224.50M-273.20M220.88M
Dividends Paid25.43M6.93M2.98M1.99M61.39M2.46M60.66M21.36M59.51M72.36M54.85M14.95M76.78M61.19M48.98M
FCF to OCF49.91%-143.01%69.91%-32.88%28.20%2.39%-57.48%-64.64%-399.08%1213.53%-156.17%120.74%40.61%173.08%87.28%
Dividend Paid to FCF109.49%-14.53%6.59%-14.47%374.50%141.53%-103.18%-28.96%-12.82%-18.40%-29.11%-1.32%34.20%-22.40%22.18%

Earnings

Report DateJun 30, 2016Oct 18, 2016Jan 18, 2017Apr 24, 2017Jul 17, 2017Oct 20, 2017Jan 22, 2018Apr 26, 2018Aug 21, 2018Oct 25, 2018Feb 25, 2019Apr 25, 2019Aug 25, 2019Oct 30, 2019Dec 31, 2019Apr 28, 2020Aug 28, 2020Oct 28, 2020Dec 31, 2020Apr 29, 2021Aug 29, 2021Oct 28, 2021Mar 4, 2022Apr 30, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Apr 27, 2023Aug 28, 2023Oct 27, 2023Dec 31, 2023Apr 26, 2024Jun 30, 2024Oct 29, 2024Dec 31, 2024Apr 21, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------
EPS Actual0.120.070.070.070.120.080.070.060.100.080.080.050.09-0.001.631.630.070.09-0.010.100.100.10-0.020.06-0.14-0.26-0.52-0.08-0.03-0.09-0.40-0.03-0.05-0.17-0.650.010.010.00-0.290.020.02
Surprise-----------------------------------------
Timing-Pre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-marketPre-marketPre-marketAfter-hoursPre-marketAfter-hoursPre-market-Pre-marketPre-marketAfter-hours-Pre-marketAfter-hoursPre-marketPre-marketPre-market---Pre-marketPre-marketAfter-hours-Pre-market-Pre-market-Pre-market-----

Key Statistics & Ratios

Market Cap5.24B
Enterprise Value5.48B
Trailing P/E0.00
Forward P/E0.00
Price / Sales2.24
Price / Book4.61
EPS-0.24
Book Value1.04
Revenue (TTM)2.34B
Gross Profit (TTM)1.25B
EBITDA58.16M
Profit Margin-10.94%
Operating Margin9.74%
Return on Equity-18.85%
Return on Assets-2.05%
Shares Outstanding1.09B
Shares Float604.66M
Beta0.26
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20221×
0.03May 13, 2022
20211×
0.05Jul 8, 2021
20201×
0.05Jun 23, 2020
20191×
0.18Apr 24, 2019
20181×
0.06Mar 12, 2018
20171×
0.18Jun 1, 2017

Stock Splits

  • Sep 23, 20191.7:1
  • Jun 1, 201720:10